A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection (NCT06008860)

🧪 Interventions in This Study

• Experimental: Primary Cohort (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Chicago — Chicago, Illinois

📞 Contact the Study Coordinator

Phone: (773) 702-6143

Email: bbaird@bsd.uchicago.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in COVID-19

• COVID-19 and Cancer Consortium Registry — Nashville, Tennessee
• Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients — Sacramento, California
• COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) — Bethesda, Maryland
• Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans — Baltimore, Maryland
• Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings — Calgary, Alberta
• A Nasal Treatment for COVID-19 — Indianapolis, Indiana

Explore by condition: All COVID-19 clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.